Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$638.74 USD

638.74
1,677,730

+5.74 (0.91%)

Updated Nov 26, 2021 01:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.42%
2Buy19.05%
3Hold10.68%
4Sell6.41%
5Strong Sell3.08%
S&P50011.42%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (188 out of 253)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for TMO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Thermo Fisher Scientific Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 10,325 2,399 2,103 1,335 786
Receivables 5,741 4,349 4,136 4,311 3,427
Notes Receivable 0 0 0 0 0
Inventories 4,029 3,370 3,005 2,971 2,213
Other Current Assets 1,862 1,775 1,381 804 595
Total Current Assets 21,957 11,893 10,625 9,421 7,021
Net Property & Equipment 5,912 4,749 4,165 4,047 2,578
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 38,726 39,728 40,325 41,974 35,297
Deposits & Other Assets 2,457 2,011 1,117 1,227 1,012
Total Assets 69,052 58,381 56,232 56,669 45,908
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 2,628 676 1,271 2,135 1,256
Accounts Payable 2,175 1,920 1,615 1,428 926
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 4,230 2,685 2,452 2,766 2,033
Income Taxes Payable 0 0 0 0 165
Other Current Liabilities 1,271 916 809 719 486
Total Current Liabilities 10,304 6,197 6,147 7,048 4,866
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,794 2,192 2,265 2,766 2,557
Convertible Debt 0 0 0 0 0
Long-Term Debt 19,107 17,076 17,719 18,873 15,372
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 3,340 3,241 2,515 2,569 1,573
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 34,545 28,706 28,646 31,256 24,368
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 437 434 432 428 415
Capital Surplus 15,579 15,064 14,621 14,177 12,140
Retained Earnings 28,116 22,092 18,696 15,914 13,927
Other Equity -2,807 -2,679 -2,498 -2,003 -2,636
Treasury Stock 6,818 5,236 3,665 3,103 2,306
Total Shareholder's Equity 34,507 29,675 27,586 25,413 21,539
Total Liabilities & Shareholder's Equity 69,052 58,381 56,232 56,669 45,908
Total Common Equity 34,507 29,675 27,586 25,413 21,539
Shares Outstanding 396.30 400.90 402.50 401.00 395.00
Book Value Per Share 87.07 74.02 68.54 63.37 54.53

Fiscal Year End for Thermo Fisher Scientific Inc. falls in the month of December.

All items in Millions except Per Share data.

9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Assets          
Cash & Equivalents 12,027 7,023 5,583 10,325 7,540
Receivables 5,557 5,476 5,554 5,741 5,186
Notes Receivable 0 0 0 0 0
Inventories 4,906 4,625 4,342 4,029 3,829
Other Current Assets 2,234 2,136 2,206 1,862 1,679
Total Current Assets 24,724 19,260 17,685 21,957 18,234
Net Property & Equipment 7,049 6,560 6,133 5,912 5,180
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 38,836 39,294 39,654 38,726 38,652
Deposits & Other Assets 2,991 2,584 2,459 2,457 1,995
Total Assets 73,600 67,698 65,931 69,052 64,061
Liabilities & Shareholders Equity 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Notes Payable 19 4 4 2,628 2
Accounts Payable 2,301 2,098 2,146 2,175 1,703
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 3,991 3,353 3,449 4,230 3,476
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1,442 1,470 1,396 1,271 1,047
Total Current Liabilities 7,753 6,925 6,995 10,304 6,228
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,465 1,632 1,885 1,794 1,528
Convertible Debt 0 0 0 0 0
Long-Term Debt 21,688 18,773 18,641 19,107 21,091
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 3,984 3,352 3,340 3,390
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 34,890 30,844 30,873 34,545 32,237
Shareholders Equity 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 439 438 438 437 437
Capital Surplus 15,960 15,826 15,684 15,579 15,467
Retained Earnings 33,876 32,076 30,350 28,116 25,705
Other Equity -2,654 -2,630 -2,562 -2,807 -2,970
Treasury Stock 8,911 8,856 8,852 6,818 6,815
Total Shareholder's Equity 38,710 36,854 35,058 34,507 31,824
Total Liabilities & Shareholder's Equity 73,600 67,698 65,931 69,052 64,061
Total Common Equity 38,710 36,854 35,058 34,507 31,824
Shares Outstanding 394.00 393.40 393.00 396.30 396.30
Book Value Per Share 98.25 93.68 89.21 87.07 80.30